The present study revealed that FCGR3A is involved in constructing the risk score cancer model, and effectively predicts patient prognosis, correlating with lower infiltration of B cells naive and CD8+ T cells, and higher infiltration of M2 Macrophages and Neutrophils. The gene discussed is FCGR3A; the disease is cancer.